300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
B2B
Facebook
Blockchain
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Web3
Medical
Theatre
Recruiting
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Nigeria
Isle of Man
Pakistan
Tunisia
Romania
Russian Federation
Togo
Tajikistan
Zimbabwe
Colombia
Oman
Cameroon
Australia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Japan
Seychelles
Germany
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Oceania (June 2026)

The most active venture capital funds investing in Oceania Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Oceania Medical startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Brandon Capital
VC Fund
11 Australia, United Kingdom, United States Series A, Seed, Series B Biotechnology, Health Care, Medical $673k–$81M
Artesian VC
VC Fund
9 Australia, United States, Hong Kong Seed, Series A, Pre-Seed Software, Artificial Intelligence, Health Care $40k–$15M
Medical Research Commercialisation Fund (MRCF)
VC Fund
7 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Medical $1.3M–$16M
Uniseed
VC Fund
5 Australia, United States, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Manufacturing $471k–$22M
Uniseed Ventures
VC Fund
4 Australia, United States, United Kingdom Series A, Seed Biotechnology, Health Care, Manufacturing $381k–$16M
Icehouse Ventures
VC Fund
4 New Zealand, United States, United Kingdom Seed, Series A Software, SaaS, Information Technology $593k–$16M
Giant Leap Fund
VC Fund
4 Australia, United States, Philippines Seed, Series A Health Care, Software, Information Technology $875k–$23M
Main Sequence Ventures
VC Fund
4 Australia, United States, Philippines Seed, Series A, Series B Software, Artificial Intelligence, Manufacturing $1M–$73M
Breakthrough Victoria
VC Fund
4 Australia, United States, Philippines Seed, Series A Health Care, Manufacturing, Biotechnology $708k–$36M
IP Group
VC Fund
3 United Kingdom, United States, Australia Seed, Series A Health Care, Biotechnology, Therapeutics $393k–$23M
Right Click Capital
VC Fund
3 Australia, Singapore, United States Seed, Series A Software, SaaS, Information Technology $200k–$16M
Fund WA
VC Fund
3 Australia Seed, Series A Medical, Health Care, Manufacturing
Clinton Capital Partners
VC Fund
3 Australia, United States Seed, Series A Software, E-Commerce, Health Care $337k–$5M
Stoic VC
VC Fund
3 Australia, United States, United Kingdom Seed, Series A Biotechnology, Medical, Health Care $600k–$16M
EVP
VC Fund
3 Australia, New Zealand, United States Series A, Seed Software, SaaS, Information Technology $942k–$5.4M
Antler
VC Fund
3 Singapore, Australia, United Kingdom Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $104k–$29M
Transition Level Investments
VC Fund
3 Australia, United States Seed, Pre-Seed, Series A SaaS, Software, Health Care $60k–$2.4M
Pacific Channel
VC Fund
2 New Zealand, Australia, Canada Seed, Series A, Pre-Seed Software, Medical Device, Biotechnology $1.1M–$5M
Horizons Ventures
VC Fund
2 United States, United Kingdom, Canada Series A, Series B, Seed Biotechnology, Software, Artificial Intelligence $1M–$110M
Larsen Ventures
VC Fund
2 Australia, United States, United Kingdom Seed, Series A, Series B Software, Education, SaaS $457k–$31M
Folklore Ventures
VC Fund
2 Australia, United States, New Zealand Seed, Series A Software, Information Technology, Apps $500k–$21M
Blackbird Ventures
VC Fund
2 Australia, United States, New Zealand Seed, Series A, Pre-Seed Software, Artificial Intelligence, SaaS $34k–$35M
Jolimont Global Mining Systems
VC Fund
2 Australia, United States Seed, Convertible Note Software, Construction, SaaS
Starfish Ventures
VC Fund
2 United States, Australia, Philippines Series A, Series B Software, Enterprise Software, Internet $2M–$18M
Sante Ventures
VC Fund
2 United States, Canada, Japan Series A, Series B, Series C Health Care, Medical, Biotechnology $1.9M–$80M
Hostplus
VC Fund
2 Australia, United Kingdom, United States Series A, Series B, Series C Biotechnology, Software, Renewable Energy $6.7M–$111M
Australian Medical Angels
VC Fund
2 Australia, Hong Kong Seed, Pre-Seed, Series A Health Care, Machine Learning, Sports
Carthona Capital
VC Fund
2 Australia, United States, United Kingdom Seed, Series A, Series B Software, Financial Services, FinTech $404k–$50M
Tyson & Blake
VC Fund
2 Australia Seed Medical, Facial Recognition, Artificial Intelligence
M8 Ventures
VC Fund
2 Australia Pre-Seed, Seed, Series A Health Care, SaaS, Medical $200k–$8M
Purpose Ventures
VC Fund
2 Australia Seed, Series A Education, EdTech, Health Care $487k–$4M
OneVentures
VC Fund
2 Australia, United States, Israel Series A, Debt Financing Software, Health Care, Biotechnology $1M–$20M
Sydney Angels
VC Fund
2 Australia, United States Seed, Angel, Pre-Seed Software, SaaS, Health Care $120k–$1.5M
Enterprise Angels
VC Fund
2 New Zealand, United States, United Kingdom Seed, Angel Software, Health Care, Information Technology $153k–$2.4M
Regal Funds Management
VC Fund
2 Australia, United States, United Kingdom Convertible Note, Series B Software, Financial Services, FinTech $1.7M–$26M
Matū Group
VC Fund
2 New Zealand, United States Seed Biotechnology, Robotics, Nanotechnology
Global from Day One
VC Fund
2 New Zealand, United States, China Seed, Series A Software, SaaS, Video $612k–$5M
HTC
VC Fund
1 United States, Taiwan, China Series A, Seed Virtual Reality, Software, Augmented Reality $1.2M–$50M
Auckland UniServices
VC Fund
1 New Zealand Seed, Pre-Seed Medical, Marketing, Health Care
VU Venture Partners
VC Fund
1 United States, Colombia, India Seed, Series A Software, Health Care, Machine Learning
Queensland Investment Corporation
VC Fund
1 Australia, United States Seed, Series A Information Technology, Software, Financial Services
Jelix Ventures
VC Fund
1 Australia, New Zealand, United States Seed, Series A Software, Information Technology, Artificial Intelligence
GD1
VC Fund
1 New Zealand, United States, China Seed, Series A, Pre-Seed Software, Information Technology, SaaS
IP Group Australia
VC Fund
1 Australia, New Zealand Seed, Pre-Seed, Series A Biotechnology, Manufacturing, Health Care
Flying Kiwi Angels
VC Fund
1 New Zealand, United States Seed, Angel, Pre-Seed Software, Information Technology, Apps $334k–$1.3M
CP Ventures
VC Fund
1 Australia, United States, India Seed, Pre-Seed Software, Artificial Intelligence, Machine Learning $350k–$3.9M
New Zealand Venture Investment Fund
VC Fund
1 New Zealand, United States, Japan Seed, Series A, Angel Software, Biotechnology, SaaS $400k–$8.8M
Lilly Ventures
VC Fund
1 United States, Israel, Australia Series C, Series B, Series A Biotechnology, Health Care, Therapeutics $6M–$65M
Skip Capital
VC Fund
1 Australia, United States, Canada Seed, Series A, Series B Software, Artificial Intelligence, SaaS $1.3M–$100M
QIC BioVentures
VC Fund
1 Australia Series A Medical, Health Care, Biotechnology
Access all 50 VC funds in Oceania Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Brandon Capital
VC Fund · Melbourne, Victoria, Australia · 11 investments in Oceania Medical startups

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 61
  • Round size: Seed $673k–$6.7M; Series A $4.9M–$81M; Series B $6.4M–$68M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $210M in 2019

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • Allay Therapeutics — SUPPORTING PATIENTS THROUGH EVERY PHASE OF RECUPERATION The first technology designed to deliver weeks of localized pain management
  • Pheon Therapeutics — Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. Its lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types.The company was founded in 2022 and is based in London,England.
Show all investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 9 investments in Oceania Medical startups

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, Hong Kong

Investor stats

  • Total investments: 227
  • Round size: Seed $120k–$5M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
  • Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Show all investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia · 7 investments in Oceania Medical startups

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 25
  • Round size: Series A $1.3M–$13M; Series B $6.4M–$16M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Denteric — Denteric is developing a vaccine based on research conducted at the University of Melbourne, with collaborative support from CSL Limited, to fight the disease and will receive the money in three parts each year from 2019 to 2021.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Show all investments...

Uniseed
VC Fund · Brisbane, Queensland, Australia · 5 investments in Oceania Medical startups

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Seed, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 84
  • Round size: Seed $600k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Lucia Bio — Lucia Bio is a biotechnology company that focuses on developing Syk inhibitors that help in the treatment of immunological diseases.
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Show all investments...

Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia · 4 investments in Oceania Medical startups

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Seed
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2017

Portfolio highlights

  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Show all investments...

Icehouse Ventures
VC Fund · Auckland, Auckland, New Zealand · 4 investments in Oceania Medical startups

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: New Zealand, United States, United Kingdom

Investor stats

  • Total investments: 184
  • Round size: Seed $593k–$5M; Series A $2.5M–$16M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — raised $69M in 2021

Portfolio highlights

  • Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
  • Caruso — AI-native fund administration for private markets. Trusted by 900+ real estate, private credit, and private equity funds to save time, impress investors, and grow AUM.
  • OpenStar Technologies — OpenStar Technologies is a renewable energy company that develops fusion reactors for baseload power to the grid.
Show all investments...

Giant Leap Fund
VC Fund · Melbourne, Victoria, Australia · 4 investments in Oceania Medical startups

Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 46
  • Round size: Seed $875k–$4.2M; Series A $2.8M–$23M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: May invest from a new fund soon — raised $9.7M in 2018

Portfolio highlights

  • Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
  • SPEC Toolbox — CLT Toolbox offers sustainable design of structural materials, using software to clear through the clutter and make design simple. CLT Toolbox is building structural design software to make mass timber as easy as concrete or steel.
  • Clean Slate Clinic — Clean Slate Clinic is a telehealth company that provides alcohol detox program who are struggling with alcohol.
Show all investments...

Main Sequence Ventures
VC Fund · Sydney, New South Wales, Australia · 4 investments in Oceania Medical startups

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Manufacturing
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 125
  • Round size: Seed $1M–$7.1M; Series A $4.5M–$29M; Series B $13M–$73M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $303M in 2023

Portfolio highlights

  • Endua — Endua is building the next generation of clean energy deep storage to power communities, remote industries and off-grid infrastructure at the flick of a switch - all day and night
  • Arlula — Arlula provides a single integration point for a global network of satellite imagery. Sign up today and get BETA access to our API.
  • QuintessenceLabs — Quantum cyberattacks can break current encryption in minutes! Get protected with QuintessenceLabs quantum key distribution, generation, and management.
Show all investments...

Breakthrough Victoria
VC Fund · Melbourne, Victoria, Australia · 4 investments in Oceania Medical startups

The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Seed, Series A
  • Geography: Australia, United States, Philippines

Investor stats

  • Total investments: 48
  • Round size: Seed $708k–$7.1M; Series A $1.8M–$36M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • World View Enterprises — World View sets the standard for stratospheric exploration via remote sensing, C4ISR and asset monitoring via stratospheric balloons, along with future space tourism and research and education offerings.
  • RayGen — We're powering the future with low cost, high efficiency solar power technology and renewable energy storage. Contact us for more details today.
  • Conflux Technology — Conflux Technology is a new generation of heat exchangers made by metal additive manufacturing (3D printing).
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 3 investments in Oceania Medical startups

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 191
  • Round size: Seed $393k–$7.6M; Series A $2M–$23M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $125M in 2014

Portfolio highlights

  • Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Right Click Capital
VC Fund · Sydney, New South Wales, Australia · 3 investments in Oceania Medical startups

Right Click Capital - Australian Venture Capital Firm

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: Australia, Singapore, United States

Investor stats

  • Total investments: 61
  • Round size: Seed $200k–$3.6M; Series A $3.3M–$16M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • black.ai — Build smarter spaces with Black.ai
  • Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
  • Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
Show all investments...

Fund WA
VC Fund · Perth, Western Australia, Australia · 3 investments in Oceania Medical startups

FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.

Show more...

Investment focus

  • Industry: Medical, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: Australia

Investor stats

  • Total investments: 7
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • Enzide — Plastic without Pollution: What if there was a way to make plastic harmless and go away when it's no longer needed? With Australia's best scientists we’ve developed super enzyme technology that makes this possible.
  • personr — Single source of truth for AML compliance
  • Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
Show all investments...

Clinton Capital Partners
VC Fund · Sydney, New South Wales, Australia · 3 investments in Oceania Medical startups

Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 67
  • Round size: Seed $337k–$2.4M; Series A $740k–$5M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!
  • Neuweb — Neuweb is an AI video analytics company that provides AI-powered solutions to control CCTV networks.
  • My Emergency Dr — A leading provider of emergency telemedicine services in Australia, My Emergency Doctor is taking the pressure off emergency care delivery.
Show all investments...

Stoic VC
VC Fund · Sydney, New South Wales, Australia · 3 investments in Oceania Medical startups

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Seed, Series A
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 24
  • Round size: Seed $600k–$4.2M; Series A $7.6M–$16M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • Lenexa Medical — Lenexa Medical is an Australian based MedTech company.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Show all investments...

EVP
VC Fund · Sydney, New South Wales, Australia · 3 investments in Oceania Medical startups

EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Series A, Seed
  • Geography: Australia, New Zealand, United States

Investor stats

  • Total investments: 105
  • Round size: Seed $942k–$3M; Series A $1.2M–$5.4M
  • Lead/follow: 71% lead, 29% follow

Portfolio highlights

  • AutoGrab — Australia's Automotive Intelligence Platform
  • Practifi — The leading wealth management CRM purpose-built for advisors, Practifi transforms how financial professionals connect with and grow their client base.
  • Smartabase — Centralize your health, medical, and performance data in Teamworks' AMS to gain a holistic view of your athletes and optimize performance.
Show all investments...

Antler
VC Fund · Singapore, Central Region, Singapore · 3 investments in Oceania Medical startups

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Singapore, Australia, United Kingdom

Investor stats

  • Total investments: 1197
  • Round size: Seed $196k–$5.8M; Pre-Seed $104k–$1.1M; Series A $4.6M–$29M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely actively investing — fresh fund, raised $72M in 2024

Portfolio highlights

  • Sapyen — We take the fear out of infertility for men. Test for it at home, without stepping out to the hospital and get personalised health recommendations to improve sperm health and increase your chances of conceiving.
  • RubiLabs — RubiLabs Inc provides a platform for unifying, monitoring, and analyzing organizational data. RubiLabs software enables analysts and operators across risk, compliance, and security teams to collaborate and interpret large volumes of information in real time. The company’s platform is designed to help institutions make sense of complex, fragmenteddata by transforming it into a coherent operational picture for risk detection, continuous monitoring, and investigative workflows.
  • One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
Show all investments...

Transition Level Investments
VC Fund · Brisbane, Queensland, Australia · 3 investments in Oceania Medical startups

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

Show more...

Investment focus

  • Industry: SaaS, Software, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 19
  • Round size: Seed $875k–$2.4M; Pre-Seed $60k–$1.5M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
  • Kapiche — Customer intelligence for CX, support and product teams who need to understand their customers accross more than just surveys. Analyze 100% of customer conversations to prevent churn and accelerate growth.
  • Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Show all investments...

Pacific Channel
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical startups

Investing in great people solving hard problems to create a better future.

Show more...

Investment focus

  • Industry: Software, Medical Device, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: New Zealand, Australia, Canada

Investor stats

  • Total investments: 19
  • Round size: Seed $1.1M–$5M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Bovonic — Bovonic is an agriculture software developer that helps dairy farmers to enhance the productivity and profitability of their animals.
  • Mars Bioimaging — MARS portable CT imaging systems bring diagnostics closer to patients with unprecedented spectral resolution and extremely low radiation doses.
  • Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
Show all investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in Oceania Medical startups

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 250
  • Round size: Seed $1M–$11M; Series A $6.2M–$50M; Series B $8M–$110M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
  • Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
  • Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.
Show all investments...

Larsen Ventures
VC Fund · Perth, Western Australia, Australia · 2 investments in Oceania Medical startups

Larsen Ventures is a lean, driven and strategic venture investment firmWe believe in alignment, long-term thinking & investor due diligence
 We like metrics, traction & perseverance
 We invest in people
1/3 of our focus is on Health and Education; 
We like the thematic & overall gains for society2/3 of our time is spentlearning from peers, digging into research, 
chasing leads & hanging out on caffeinated zooms in the endless search for;Founders with Traction 
Founders with Insight
 Founders with Perseverance and Courage 
Founders with an innate ability to question EverythingWe have patient capital that engages & contributes to your Journey 
Accelerate your business with our portfolios' intellectual capital

Show more...

Investment focus

  • Industry: Software, Education, SaaS
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 27
  • Round size: Seed $457k–$8M; Series A $500k–$15M; Series B $4.4M–$31M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
  • OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
  • Seedflex Technologies — Pay-As-You-Sell Advance for Merchants; A frictionless way for merchants to stay in control of their business, capital, and growth
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Folklore Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

Show more...

Investment focus

  • Industry: Software, Information Technology, Apps
  • Stage:Seed, Series A
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 47
  • Round size: Seed $725k–$5M; Series A $500k–$21M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Arkeus — Arkeus is a leader in the fusion of optics and autonomy. Our wide area autonomous optical systems are deployed to conduct Search, Intelligence, Surveillance and Reconnaissance in a range of operating environments.
  • Hullbot — Hullbot is a developer of a robotic in-water cleaning system designed to inspect, map, and clean the hull of a boat without a human operator present. They offer design, development, and deployment of autonomous drones, delivering solutions to stop the growth of marine organisms, improve performance, and extend the time between haul-outs. Theirembedded intelligence enables their robots to interact with the environment on-the-fly.
  • Sphere — Live courses led by vetted experts for professionals who want to advance their careers
Show all investments...

Blackbird Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Australia, United States, New Zealand

Investor stats

  • Total investments: 311
  • Round size: Seed $34k–$7.1M; Pre-Seed $50k–$3M; Series A $3.4M–$35M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

Jolimont Global Mining Systems
VC Fund · Denver, Colorado, United States · 2 investments in Oceania Medical startups

Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.

Show more...

Investment focus

  • Industry: Software, Construction, SaaS
  • Stage:Seed, Convertible Note
  • Geography: Australia, United States

Investor stats

  • Total investments: 5
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
  • APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
  • QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Show all investments...

Starfish Ventures
VC Fund · Melbourne, Victoria, Australia · 2 investments in Oceania Medical startups

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Show more...

Investment focus

  • Industry: Software, Enterprise Software, Internet
  • Stage:Series A, Series B
  • Geography: United States, Australia, Philippines

Investor stats

  • Total investments: 53
  • Round size: Series A $2M–$6.6M; Series B $2.5M–$18M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: May invest from a new fund soon — raised $134M in 2008

Portfolio highlights

  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Show all investments...

Sante Ventures
VC Fund · Austin, Texas, United States · 2 investments in Oceania Medical startups

Privately Held Companies

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: United States, Canada, Japan

Investor stats

  • Total investments: 115
  • Round size: Series A $1.9M–$32M; Series B $2.6M–$61M; Series C $5M–$80M
  • Lead/follow: 61% lead, 39% follow
  • Last fund: Likely still investing — raised $260M in 2021

Portfolio highlights

  • Sonire Therapeutics — Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.
  • SONIRE Therapeutics — SONIRE Therapeutics is a clinical-stage medical device company. It is a U.S. subsidiary of SONIRE Therapeutics Co., Ltd..
  • Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Show all investments...

Hostplus
VC Fund · Melbourne, Victoria, Australia · 2 investments in Oceania Medical startups

Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!

Show more...

Investment focus

  • Industry: Biotechnology, Software, Renewable Energy
  • Stage:Series A, Series B, Series C
  • Geography: Australia, United Kingdom, United States

Investor stats

  • Total investments: 61
  • Round size: Series A $6.7M–$49M; Series B $20M–$111M; Series C $13M–$60M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Myriota — Myriota delivers cutting-edge IoT technology through low-cost, low-power satellite connectivity for global remote monitoring.
  • Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show all investments...

Australian Medical Angels
VC Fund · 2 investments in Oceania Medical startups

Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.

Show more...

Investment focus

  • Industry: Health Care, Machine Learning, Sports
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, Hong Kong

Investor stats

  • Total investments: 9
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
  • Clean Slate Clinic — Clean Slate Clinic is a telehealth company that provides alcohol detox program who are struggling with alcohol.
  • Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Show all investments...

Carthona Capital
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 111
  • Round size: Seed $404k–$4.2M; Series A $3.3M–$17M; Series B $9.8M–$50M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $100M in 2022

Portfolio highlights

  • Pathzero — Pathzero's carbon management platform enables any business to start disclosing corporate carbon emissions and the actions being taken to address them.
  • CoverRight — Use CoverRight's tools to find a personalized Medicare plan and get the best coverage for your situation! Compare and enroll in Medicare Advantage, Medigap, and Prescription Drug Plans, all in one place.
  • Lounge — Use Lounge to organise events and groups in seconds, without a newsfeed. Stop scrolling, start living.
Show all investments...

Tyson & Blake
VC Fund · London, England, United Kingdom · 2 investments in Oceania Medical startups

Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.

Show more...

Investment focus

  • Industry: Medical, Facial Recognition, Artificial Intelligence
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
Show all investments...

M8 Ventures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Great tech startup businesses are built by amazing product teams

Show more...

Investment focus

  • Industry: Health Care, SaaS, Medical
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Australia

Investor stats

  • Total investments: 6
  • Round size: Seed $3M–$8M; Pre-Seed $200k–$1M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
  • Flowing Bee — Revolutionise your customer interactions using AI, customer and behavioural insights. We create powerful marketing communications that drive behaviour change.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Purpose Ventures
VC Fund · Subiaco, Western Australia, Australia · 2 investments in Oceania Medical startups

Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.

Show more...

Investment focus

  • Industry: Education, EdTech, Health Care
  • Stage:Seed, Series A
  • Geography: Australia

Investor stats

  • Total investments: 9
  • Round size: Seed $487k–$4M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • Coursebox — Coursebox is an AI-native course creator and LMS. Turn a prompt, PDF or existing document into a full interactive course in minutes — complete with AI-avatar training videos, multilingual voiceovers, quizzes and assessments with automatic grading, and a 24/7 AI tutor for learners. Deliver everything inside a fully branded, white-label portal,monetize with Stripe and PayPal, and export via SCORM/LTI. Coursebox helps creators, businesses and L&D teams build and sell professional training at a fraction of the usual time and cost.
  • SpacetoCo — Australia & New Zealand's favourite way to book spaces, community halls and meeting rooms by the hour.
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Show all investments...

OneVentures
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Debt Financing
  • Geography: Australia, United States, Israel

Investor stats

  • Total investments: 77
  • Round size: Series A $1.5M–$20M; Debt Financing $1M–$6.7M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — raised $145M in 2022

Portfolio highlights

  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • Kira Biotech — Kira Biotech is an emerging Australian biotechnology company developing novel immunomodulatory compounds for the treatment of immune system disorders. Its lead candidate, KB312, is a first-in-class, selective, immune-cell depleting monoclonal antibody which targets activated immune cells and aims to restore homeostasis through induction of immunetolerance. Kira Biotech has attracted venture capital funding and is progressing KB312 through preclinical development and phase 1 clinical trials with a team of drug development experts led by well-known US-based rheumatologist and immunologist, Dr Dan Baker.
  • Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Show all investments...

Sydney Angels
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Australia, United States

Investor stats

  • Total investments: 94
  • Round size: Seed $120k–$1.3M; Angel $130k–$890k; Pre-Seed $337k–$1.5M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Quizling — Quizling is an educational app that allows its users to make quick quizzes on their iPhone or iPad. Its users have the ability to plug their iPhone or iPad into their smart board or digital projector and challenge their class.Quizling is designed for teachers, students, and classrooms. Its aim is to make a teacher’s life easier, a student’slearning more interesting and challenging, and to help make the classroom a fun and engaging place. It can be used to preview a topic and check prior learning or before a test. Students also have the opportunity to make their own quizlings and challenge each other.Quizling was launched in 2012.
  • ExtrasJar — Swap health insurance premiums for balanced investments and get access to your funds when using health services.
  • Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Show all investments...

Enterprise Angels
VC Fund · Tauranga, Gisborne, New Zealand · 2 investments in Oceania Medical startups

Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Angel
  • Geography: New Zealand, United States, United Kingdom

Investor stats

  • Total investments: 106
  • Round size: Seed $153k–$2.4M; Angel $229k–$651k
  • Lead/follow: 8% lead, 92% follow
  • Last fund: May invest from a new fund soon — raised $12M in 2019

Portfolio highlights

  • Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
  • HealthNow — HealthNow provides accessible healthcare services that give you control of your health. Manage how you access care, when you need it.
  • Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
Show all investments...

Regal Funds Management
VC Fund · Sydney, New South Wales, Australia · 2 investments in Oceania Medical startups

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Show more...

Investment focus

  • Industry: Software, Financial Services, FinTech
  • Stage:Convertible Note, Series B
  • Geography: Australia, United States, United Kingdom

Investor stats

  • Total investments: 77
  • Round size: Series B $7M–$26M; Convertible Note $1.7M–$17M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $54M in 2022

Portfolio highlights

  • Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
  • Firmus Technologies
  • Iondrive — Iondrive is an exploration company that provides metals. They offer products that include gold, silver, copper, and other metals. They provide services for industrial use.
Show all investments...

Matū Group
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical startups

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

Show more...

Investment focus

  • Industry: Biotechnology, Robotics, Nanotechnology
  • Stage:Seed
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 8
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ligar — Revolutionising molecular extraction through nanotechnology (molecularly imprinted polymers)
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • PowerON — Dielectric Elastomers for Soft Robotics
Show all investments...

Global from Day One
VC Fund · Auckland, Auckland, New Zealand · 2 investments in Oceania Medical startups

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Show more...

Investment focus

  • Industry: Software, SaaS, Video
  • Stage:Seed, Series A
  • Geography: New Zealand, United States, China

Investor stats

  • Total investments: 29
  • Round size: Seed $612k–$5M; Series A $1.2M–$3M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $90M in 2021

Portfolio highlights

  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
Show all investments...

HTC
VC Fund · Taoyüan, T'ai-wan, Taiwan · 1 investments in Oceania Medical startups

HTC Corp is engaged in the design, development, and manufacture of smartphones and tablets in Taiwan.The company offers PDA phones and smartphones for mobile operators and distributors in Europe, the United States, and Asia. These machines are available as HTC devices and as products individually customized for operators and device partners.The company provides its own HTC self-branded products as well as supports operator-branded products and original equipment manufacturer (OEM) partners. It owns Dopod as a subsidiary company and is a member of the Open Handset Alliance.The company’s products are sold under various brand names such as HTC, Dopod, and Qtek and are often rebranded by major telecommunication carriers. Its products also include pocket PC phones (PDA Phone), ultra mobile phones, HTC kovsky (Sony Ericsson XPERIA X1), and HTC dream (T-mobile G1).HTC Corp was founded by Cher Wang and Peter Chou in 1997. It is headquartered in New Taipei City, Taiwan.

Show more...

Investment focus

  • Industry: Virtual Reality, Software, Augmented Reality
  • Stage:Series A, Seed
  • Geography: United States, Taiwan, China

Investor stats

  • Total investments: 42
  • Round size: Seed $1.2M–$9M; Series A $2.2M–$50M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2017

Portfolio highlights

  • Bitmark — An archive of digital property rights infrastructure.
  • Hexa — Elevate your eCommerce experience with a 3D tech-stack that lets you create, manage, analyze, and distribute your 3D commerce assets.
  • Oatside — Indulge in creamy oat milk for non-plant milk lovers. Explore Barista Blend, Chocolate, and Oat Latte. Shop now.
Show all investments...

Auckland UniServices
VC Fund · Perth, Western Australia, Australia · 1 investments in Oceania Medical startups

At UniServices, we partner with the University of Auckland to transform ideas into real-world solutions that impact globally.

Show more...

Investment focus

  • Industry: Medical, Marketing, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: New Zealand

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Show all investments...

VU Venture Partners
VC Fund · San Francisco, California, United States · 1 investments in Oceania Medical startups

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

Show more...

Investment focus

  • Industry: Software, Health Care, Machine Learning
  • Stage:Seed, Series A
  • Geography: United States, Colombia, India

Investor stats

  • Total investments: 85
  • Lead/follow: no public data

Portfolio highlights

  • Hadean — Hadean are a venture backed tech startup providing the most simple and secure platform for cloud native development. Intuitive and developer friendly, the Hadean Platform provides a friction free route to a cloud-native infrastructure. It lets you write applications once and deploy anywhere, taking care of setup, configuration, scaling, securityand more.Hadean have developed two flagship applications. Aether Engine provides distributed load balancing for agent-based simulations, while Muxer is a network model that utilises distributed edge networks. The result is spatial simulations of unparalleled size and complexity, where thousands of concurrent users can join and interact. Hadean have found traction in gaming, healthcare, virtual events and defence with industry leading companies such as Microsoft, Minecraft and CAE.
  • MarketForce — MarketForce connects Africa’s informal retail outlets and consumers directly to suppliers of consumer goods and financial services by digitizing orders, delivery, and payments with the aim of solving the last mile distribution challenge.
  • Dayta AI — SaaS Shopper Analytics - Cyclops presents you insightful data like shopper demographics, bahavioral metrics and many more. Drive more sales and traffic with AI now!
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Queensland Investment Corporation
VC Fund · Brisbane, Queensland, Australia · 1 investments in Oceania Medical startups

Queensland Investment Corporation is an investment company.

Show more...

Investment focus

  • Industry: Information Technology, Software, Financial Services
  • Stage:Seed, Series A
  • Geography: Australia, United States

Investor stats

  • Total investments: 16
  • Lead/follow: no public data

Portfolio highlights

  • Gelomics — Gelomics operates as a biotechnology company. Gelomics provides 3D cell culture technologies.
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • Renewa — Renewa accelerates the transition to renewables by helping landowners achieve financial security and by providing capital solutions to developers.
Show all investments...

Jelix Ventures
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical startups

Jelix is an early-stage venture capital firm backing daring founders in Australia and New Zealand.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Australia, New Zealand, United States

Investor stats

  • Total investments: 52
  • Lead/follow: no public data

Portfolio highlights

  • PropHero — Invest wisely in real estate There is an easier way to invest in real estate. Whether you are just getting started or already on your investment journey, at Pro
  • Fugu — Cheap green carbon at scale for the dawn of the e-fuel age
  • Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Show all investments...

GD1
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical startups

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: New Zealand, United States, China

Investor stats

  • Total investments: 43
  • Lead/follow: no public data

Portfolio highlights

  • EarnOS — EarnOS is the fully remote company that provides Global Ad & Payments Platform powered by Web3.
  • Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
  • Ivo — Ivo reduces the time, effort, and cost of negotiating agreements.
Show all investments...

IP Group Australia
VC Fund · Surry Hills, New South Wales, Australia · 1 investments in Oceania Medical startups

Ip Group Australia build and support outstanding intellectual property-based companies.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Health Care
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Australia, New Zealand

Investor stats

  • Total investments: 13
  • Lead/follow: no public data

Portfolio highlights

  • Azaneo — Azaneo develops lightning-fast electric weeding technology. Using only electrons - herbicide free.
  • Hysata — Hysata is a developer of hydrogen electrolyzer designed to accelerate the world's shift away from fossil fuels to green hydrogen
  • ElectraLith — The cleanest, most versatile and most cost-efficient method of extracting and refining lithium, the primary element of a sustainable future.
Show all investments...

Flying Kiwi Angels
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical startups

Flying Kiwi Angels ? Helping Kiwi Startups

Show more...

Investment focus

  • Industry: Software, Information Technology, Apps
  • Stage:Seed, Angel, Pre-Seed
  • Geography: New Zealand, United States

Investor stats

  • Total investments: 16
  • Round size: Seed $334k–$1.2M; Angel $592k–$918k; Pre-Seed $473k–$1.3M
  • Lead/follow: 63% lead, 37% follow

Portfolio highlights

  • PAM NZ
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
Show all investments...

CP Ventures
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical startups

The CP Ventures Fund invests in early-stage technology companies that are highly scalable, at the forefront of breakthrough technologies, and driven by the fourth industrial revolution.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Pre-Seed
  • Geography: Australia, United States, India

Investor stats

  • Total investments: 58
  • Round size: Seed $417k–$3.9M; Pre-Seed $350k–$900k
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
  • Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
  • Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.
Show all investments...

New Zealand Venture Investment Fund
VC Fund · Auckland, Auckland, New Zealand · 1 investments in Oceania Medical startups

New Zealand Venture Investment Fund, a New Zealand-based private equity fund, manages fund of funds investments and direct co-investments.

Show more...

Investment focus

  • Industry: Software, Biotechnology, SaaS
  • Stage:Seed, Series A, Angel
  • Geography: New Zealand, United States, Japan

Investor stats

  • Total investments: 35
  • Round size: Seed $428k–$1.2M; Angel $400k–$4.3M; Series A $1.4M–$8.8M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
  • Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
Show all investments...

Lilly Ventures
VC Fund · Indianapolis, Indiana, United States · 1 investments in Oceania Medical startups

Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series C, Series B, Series A
  • Geography: United States, Israel, Australia

Investor stats

  • Total investments: 72
  • Round size: Series A $8.9M–$35M; Series B $15M–$65M; Series C $6M–$55M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • NewLimit — NewLimit is extending human healthspan by unlocking regenerative potential.
  • IpiNovyx Bio — Orange Grove Bio partners with leading research universities to advance preclinical biotech programs in the oncology space. The company leverages its venture capital and drug development expertise to help patients and build biotech ecosystems.
  • Quarry Thera — Quarry Thera is a biotech company distinguished by its innovative therapeutic pipeline and an unprecedented platform that enables the development of cutting-edge treatments with the potential to address significant unmet medical needs.
Show all investments...

Skip Capital
VC Fund · Sydney, New South Wales, Australia · 1 investments in Oceania Medical startups

Skip Capital is a private investment fund investing in technology and infrastructure

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Series B
  • Geography: Australia, United States, Canada

Investor stats

  • Total investments: 80
  • Round size: Seed $1.3M–$9M; Series A $4M–$50M; Series B $10M–$100M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Reejig — At Reejig, we believe in zero wasted potential in people and in business – and that starts with harnessing the skills you have within your organisation. Our workforce intelligence platform provides 100% visibility of your people’s skills, potential, passions and experiences, creating a powerful central nervous system for all talent decisions.Powered by the world’s first independently audited Ethical Talent AI engine, Reejig generates the intelligence to instantly fill roles, track retention risks, mobilise talent to opportunities, pivot talent for reskilling and much more. Plus, we give you the power to ‘nudge’ people to new career opportunities, taking your engagement with internal and external talent to the next level. Put simply, we make workforce agility a reality.Reejig is trusted and used by some of the largest and most complex organisations including Woolworths, KPMG, NSW Government, John Holland, MYOB and UTS, and together we are creating a world where everyone can reach their full potential at work. It’s what we call zero-wasted potential in people and in business.
  • Brighte — Brighte makes solar, battery and home improvements affordable for Aussies with easy finance and a network of trusted tradies.
  • WORK180 — WORK180 is a global jobs network that operates at the forefront of a new workplace revolution. Our function is twofold.As an advocate for working women, we provide job applicants with a transparent directory of endorsed employers who support diversity, inclusion and equality.We share information around pay equity, flexible working, paidparental leave, equal opportunities and a range of other important criteria. Before an employer comes on board, we put them through a pre-screening process and on average, about 80% of companies who apply to work with us, pass our criteria.
Show all investments...

QIC BioVentures
VC Fund · Brisbane, Queensland, Australia · 1 investments in Oceania Medical startups

QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
  • Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Oceania Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists